23 April 2014
PHOSPHAGENICS COMPLETES ENROLMENT IN PHASE 2 ACNE TREATMENT TRIAL
Phosphagenics today announced that it has completed enrolment for its Phase 2 clinical trial of the Company's improved treatment for the common skin disorder acne vulgaris.
View our latest news releases/presentations/newsletters:
PHOSPHAGENICS INVESTOR WEBCAST PRESENTATION
If you wish to listen to the webcast held, register here:
17 March 2014
PHOSPHAGENICS NEWSLETTER MARCH 2014
3 March 2014
PHOSPHAGENICS APPOINTS THREE NEW NON-EXECUTIVE DIRECTORS
Phosphagenics has appointed
biotech industry veterans Mr Lawrence Gozlan, Mr Nathan Drona and Dr
Geert Cauwenbergh as non-executive directors, with Mr Gozlan assuming
the role of Chairman of the Board on an interim basis.
Mr Stuart James, Dr Sandra Webb, Mr Don Clarke and Mr Jonathan Addison
have retired from the Board. The Company thanks them for their
contributions over many years.